Improve antibiotics access to beat ‘silent pandemic’

The article describes how the Foundation's report uses case studies, "to illustrate how pharmaceutical companies can steer around such complex challenges and make antibiotics and antifungals more widely available."

The author quotes Marijn Verhoef, Director of Operations and Research at the Access to Medicine Foundation, saying: “Ensuring that such initiatives move from being the exception to the norm, supported by excellent stewardship measures to help prevent the spread of resistant infections will require commitment and partnership from all sides.”